Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate left ventricular systolic ejection fraction and anterior or apical akinesis 1 month and 3 months after a myocardial infarction treated with primary PCI to determine whether improvement at 1 month differs from improvement at 3 months.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Start Date
March 1, 2010
Primary Completion Date
June 1, 2012
Completion Date
December 1, 2012
Last Updated
July 8, 2013
42
ACTUAL participants
Lead Sponsor
Paul Farand
NCT05198791
NCT06744322
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07301034